Somashekar Krishna, MD, MPH
@som_krishna
Followers
1K
Following
575
Media
87
Statuses
348
Professor of Medicine, Director of Advanced Endoscopy, The Ohio State University Wexner Medical Center @OSUWexMed #OSUGHNDivision #OSUAdvEndo
Ohio, USA
Joined May 2009
Technique of EUS-RFA of BD-IPMN 1. Appropriate risk estimation (EUS-endomicroscopy, NGS, cytology/ Kyoto guidelines) 2. Non-operative subjects 3. EUS-RFA procedure 📽️⬇️ - Aspirate cyst (target for RFA) - EUS-RFA of multiple foci by maneuvering needle - Watch for impedance spike
3
7
48
Join the GI Division @ OSU! ⭐️We’re recruiting #Gastroenterologists across all subspecialties! 👩⚕️45 Faculty | 19 Fellows 🔬$5M in #research funding 💥2 Compensation Tracks (academic & clinical) 📩 If passionate about academic medicine & innovation, I’d love to connect
2
13
58
Three publications mark our journey from manually curated endomicroscopy (nCLE) videos ➡️ fully autonomous AI model (nCLE AI) that classifies dysplasia in IPMNs. 💡Our latest study - AI outperforming human experts. Congratulations to the OSU AI team, #CLIMB study collaborators!
3
12
58
🟢 Cases from our #CLIMB Study @som_krishna. 70s 👵 5.4 cm multilocular cyst in HOP. Fluid FNA: Gluc 188, CEA < 4, VHL. EUS below ⬇️ nCLE video ▶️ below ⬇️: Fern-patern Vascularity MicroBx: Serous Cystadenoma
2
1
12
💡The 3rd Annual Pancreatic Cyst Consortium at #DDW2025? Watch the 🎥full session recording ⬇️ ✅ Diagnosis, risk stratification, management, AI, EUS-guided ablation, coding & billing, & the latest advances in the field. Details: https://t.co/Kpizc0jDxk
1
8
30
⭐️Extremely proud for the #OSUGHNDivision @DDWMeeting #DDW2025! 2️⃣0️⃣ podium presentations 3️⃣8️⃣ posters ⭐️What an awesome group of #GI Faculty & fellows! ⭐️@OSUWexMed Scarlet & Gray Reception was also a huge success! Thank you all for stopping by @AmerGastroAssn @ASGEendoscopy
3
8
51
3rd Annual Pancreatic Cyst Consortium at #DDW2025! great turnout, engaging talks, lively discussion! Huge thanks to all our incredible speakers, dedicated attendees, and industry sponsors for making it a success.
2
3
20
1
2
11
May 6 – Tuesday 🎤 Oral Presentation Safety & Efficacy of EUS-RFA for BD-IPMNs: ERASE Study: 30 BD-IPMNs underwent RFA- outcomes (40% complete vol response, 80% > 50% vol response; ~80% molecular response) overall 82% clinical (vol/molecular) response. Safety: 12% adv events.
1
0
2
🗓️ May 5 – Monday 🎤 Oral PresentationIs It Time to Refine Our Standards? Insights from the Multicenter (12 centers) Prospective CLIMB Study on EUS-NCLE for Diagnosing Pancreatic Cystic Lesions #Fadi_Hawa #CLIMB Study
1
1
4
@EricaParkMD A Novel Dry-Suction EUS-FNB Yields Superior Diagnostic Yield Compared with TTNB in Serous Cystadenomas
1
2
5
🖼️Poster Presentation: Can EUS-nCLE improve diagnosis of pancreatic cysts beyond standard-of-care (CEA, glucose, cytology): Multiobserver cohort adding EUS-nCLE boosted accuracy from 90% → 96% for mucinous vs non-mucinous and improved detection of each PCL subtype #Fred_Karaisz
1
3
5
🖼️Poster Presentations AI Advances Digital Pathomics for Confocal Endomicroscopy-the nuts and bolts of how we built the nCLE-AI algorithm (published @AGA_TIGE
https://t.co/vRLWhnognh)
@Ahmed1Abdelbaki
1
1
3
May 3 – Saturday 🖼️Poster Presentations Intracystic Vascular Morphology as a Novel Approach to Risk Stratification of IPMNs in nCLE. Progressive dysplasia is associated with neovascularization that nCLE can detect @Ahmed1Abdelbaki
1
1
3